Table 2.
Age group | Number tested | Positives (n/%) | Tested* | Positives (n/%) PCR* | ||
---|---|---|---|---|---|---|
Microscopy | UCAA– | SCAA– | ||||
2–9 | 32 | 0 | 3/9.4 | 4/13 | 26 | 2/7.7 |
10–19 | 58 | 0 | 12/20 | 12/21 | 39 | 3/7.7 |
20–29 | 38 | 0 | 16/42 | 16/42 | 17 | 5/29 |
30–39 | 43 | 3/7 | 20/47 | 20/47 | 20 | 6/30 |
40–49 | 35 | 1/2.8 | 11/31 | 14/40 | 14 | 1/7.1 |
50–59 | 23 | 0 | 9/39 | 6/26 | 5 | 2/40 |
>60 | 29 | 0 | 9/31 | 10/35 | 7 | 0 |
Total | 258 | 4/1.6 | 80/31 | 82/32 | 128 | 19/15 |
UCAA–: UCP-LF CAA assay detecting circulating anodic antigen in urine, indecisive results were considered as negative; SCAA–: UCP-LF CAA assay detecting circulating anodic antigen in serum, indecisive results were considered as negative;
PCR was performed by sampling (n = 128).